Skip to main content
Log in

Anticarcinoembryonic antigen immunoscintigraphy with a99mTc-Fab′ fragment (Immu 4TM) in primary and recurrent colorectal cancer

A prospective study

  • Original Contributions
  • Published:
Diseases of the Colon & Rectum

Abstract

Forty-seven patients were submitted to 68 radioimmunoscintigraphic investigations for primary or recurrent colorectal cancer. Immunoscintigraphy with Immu-4 tm correctly detected 28 primary colorectal cancers of 29 and 12 of 12 recurrent colorectal cancers. Overall accuracy was 93.75 percent in primary and 91.6 percent in recurrent colorectal cancer. Immunoscintigraphy had a decisive influence on treatment planning in every third primary colorectal cancer patient and was by far superior to CT scan in the detection of early recurrences, especially in patients with a history of abdominoperineal or low anterior resection. Immu-4 tm scintigraphy is a safe and convenient diagnostic approach to colorectal cancer. Because radioactivity is acceptably low and the method is absolutely free of side effects, there are no objections to the repeated use of immunoscintigraphy which provides important information in primary diagnosis as well as in the follow-up of colorectal cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Moss AA. Imaging of colorectal carcinoma. Radiology 1989;170:308–10.

    PubMed  Google Scholar 

  2. Freeny PC, Marks WM, Ryan JA, Bolen JW. Colorectal carcinoma evaluation with CT: preoperative staging and detection of recurrences. Radiology 1986;158: 347–53.

    PubMed  Google Scholar 

  3. Pickren NJ, Tsukaday P, Lane WW. Liver metastases—analysis and autopsy data. In: Weiss L, Gilver HA, eds. Liver metastases. Boston: GK Hall, 1982: 2–18.

    Google Scholar 

  4. Finlay IG, McArdle CS. Occult hepatic metastases in colorectal cancer. Br J Surg 1986;73:732–5.

    PubMed  Google Scholar 

  5. Lind P, Lechner P, Arian-Schad K,et al. Anti-carcinoembryonic antigen immunoscintigraphy (Tc-99m MAb BW 431/26) and serum-CEA-levels in patients with suspected primary and recurrent colorectal carcinoma. J Nucl Med 1991;32:1319–25.

    PubMed  Google Scholar 

  6. Kronberger L, Lechner P, Lind P, Fueger F, Germann R, Cesnik H. Results of CEA-assays in diagnosis and follow-up of colorectal cancer. In: Kronberger L, ed. Abstract book of the XIIIth Biennial Congress of the International Society of University Colon and Rectal Surgeons, June 24–28 Graz, Austria. Wien: Blackwell MZV, 1990:90.

    Google Scholar 

  7. Bosslet K, Lueben G, Schwarz A,et al. Immunohistochemical localization and molecular characteristics of three monoclonal antibody-defined epitopes on carcinoembryonic antigen. Int J Cancer 1985;36: 75–84.

    PubMed  Google Scholar 

  8. Koehler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specifity. Nature 1975;256:494–7.

    Google Scholar 

  9. Goldenberg DM, Ford EH, Lee RE,et al. Cancer imaging with a new 99m-Tc-antibody method (abstr). Eur J Nucl Med 1989;15:426.

    Google Scholar 

  10. Lind P, Lechner P, Hausmann B,et al. Development of human antimouse antibodies (HAMA) after single and repeated diagnostic application of intact murine monoclonal antibodies. Antibody Immunoconjugates Radiopharmaceut 1991;4:811–18.

    Google Scholar 

  11. Serafini AN, Garty I, Jacobi AM. Monoclonal antibody imaging, clinical and technical perspectives. Antibody Immunoconjugates Radiopharmaceut 1989;2: 225–34.

    Google Scholar 

  12. Chang LT. A method of attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 1978;25:638–43.

    Google Scholar 

  13. Bischof-Delaloye A, Delaloye B, Buchegger F, Mach JP. Immunoscintigraphy with123I-labeled monoclonal anti-carcinoembryonic antibodies in the diagnosis and follow-up of patients with colorectal carcinoma. In: Eber O, Lind P, Langsteger W, eds. Modern aspects of tumor diagnosis and treatment. Wien: Blackwell MZV, 1991:56–63.

    Google Scholar 

  14. Haller DG. Monoclonal antibody imaging in the management of patients with colorectal cancer. J Clin Oncol 1988;6:1213–5.

    PubMed  Google Scholar 

  15. Doerr R, Abdel-Nabi H, Krag D, Mitchell E. Radiolabeled antibody imaging in the management of colorectal cancer—results of a multicenter clinical study. Ann Surg 1991;214:118–24.

    PubMed  Google Scholar 

  16. Lind P, Langsteger W, Koeltringer P,et al.99mTc-labeled monoclonal anti-carcino-embryonic antibody (BW 431/26). Clinical results in the detection of colorectal carcinomas and recurrences. Scand J Gastroenterol 1989;24:1205–11.

    PubMed  Google Scholar 

  17. Klose KJ, Dueber C, Kempf P. Stellenwert der computertomographie in der diagnostik des lokalen beckenrezidivs. Fortschr Röntg Neun 1982;136: 538–42.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Read at the meeting of The American Society of Colon and Rectal Surgeons, San Francisco, California, June 7 to 12, 1992.

About this article

Cite this article

Lechner, P., Lind, P., Binter, G. et al. Anticarcinoembryonic antigen immunoscintigraphy with a99mTc-Fab′ fragment (Immu 4TM) in primary and recurrent colorectal cancer. Dis Colon Rectum 36, 930–935 (1993). https://doi.org/10.1007/BF02050628

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02050628

Key words

Navigation